A new test can identify pancreatic cancer by urine analysis
Pancreatic cancer is one of the deadliest cancer diseases. Its early diagnosis may save a patient’s life. According to Remedium, clinical trials of a test system capable of diagnosing pancreatic cancer, even at an early stage, by urine analysis, are initiated in the UK.
If the trials are successful, this will be the first such diagnostic analysis. It is known that the test system detects the presence of three specific proteins in the sample. These proteins are biological markers of early stage pancreatic cancer.
Studies have shown that these biomarkers can identify the disease with 95% accuracy. More than 3,000 people will participate in the clinical trial. The clinical trial is going to cover the period of four years. After receiving the results, a registration application will be considered.